Polarized Supramolecular Aggregates Based on Luminescent Perhalogenated Gold Derivatives

Mono- and Dinuclear Gold(I) Coumarin Complexes: Luminescence Studies and Singlet Oxygen Production

The 4-(thiolmethyl)-7-(diethylamino)-2H-chromen-2-one ligand has been synthesized and used as chromophore in several mono- and dinuclear gold(I) compounds that contain a phosphane at the second coordination position. Four final products were able to obtain in pure form containing one coumarin and one phosphane ligand in the case of PTA (1,3,5-triaza-7-phosphatricyclo[3.3.1.13.7]decane) and PPh₃ (triphenylphosphine); one coumarin and two gold(I)-phosphane groups in the case of phosphane=DAPTA (3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane) and two coumarin and two gold(I) atoms in the case of phosphane=DPEphos (bis[(2-diphenylphosphino)phenyl]ether), when it was used a diphosphane. Other diphosphane ligands used were not able to give the desired products in pure form. The luminescent properties of the compounds are governed by the fluorescence of the coumarin moiety in all compounds both for measurements carried out in solution and also immobilized in PMMA organic matrix. Phosphorescence emission can be detected in all cases at 77 K both for the uncoordinated coumarin ligand and the gold(I) derivatives, being more favoured in the presence of the gold(I) heavy atom. The compounds have been used as photosensitizers to generate ¹ O₂ with moderate quantum yields values.

Gold(i) complexes bearing a PNP-type pincer ligand: photophysical properties and catalytic investigations

The synthesis and characterization of two dinuclear and five tetranuclear gold(i) complexes bearing the 2,6-bis(diphenylphosphinomethyl)pyridine diphosphane ligand (DPPMPY) are herein reported.

Aggregation versus Biological Activity in Gold(I) Complexes. An Unexplored Concept

The aggregation process of a series of mono- and dinuclear gold(I) complexes containing a 4-ethynylaniline ligand and a phosphane at the second coordination position (PR3-Au-C≡CC6H4-NH2, complexes 1-5, and (diphos)(Au-C≡CC6H4-NH2)2, complexes 6-8), whose biological activity was previously studied by us, has been carefully analyzed through absorption, emission, and NMR spectroscopy, together with dynamic light scattering and small-angle X-ray scattering. These experiments allow us to retrieve information about how the compounds enter the cells. It was observed that all compounds present aggregation in fresh solutions, before biological treatment, and thus they must be entering the cells as aggregates. Inductively coupled plasma atomic emission spectrometry measurements showed that mononuclear complexes are mainly found in the cytosolic fraction; the dinuclear complexes are mainly found in a subsequent fraction composed of nuclei and cytoskeleton. Additionally, dinuclear complex 8 affects the actin aggregation to a larger extent, suggesting a cooperative effect of dinuclear compounds.

1,3,5-Triaza-7-Phosphaadamantane (PTA) as a 31P NMR Probe for Organometallic Transition Metal Complexes in Solution

Due to the rigid structure of 1,3,5-triaza-7-phosphaadamantane (PTA), its ³¹P chemical shift solely depends on non-covalent interactions in which the molecule is involved. The maximum range of change caused by the most common of these, hydrogen bonding, is only 6 ppm, because the active site is one of the PTA nitrogen atoms. In contrast, when the PTA phosphorus atom is coordinated to a metal, the range of change exceeds 100 ppm. This feature can be used to support or reject specific structural models of organometallic transition metal complexes in solution by comparing the experimental and Density Functional Theory (DFT) calculated values of this ³¹P chemical shift. This approach has been tested on a variety of the metals of groups 8-12 and molecular structures. General recommendations for appropriate basis sets are reported.